Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “treatment”

2,520 pharma patents match "treatment" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,520
Index total 30,257
Page 64 / 105

Quick answer

This filtered view shows 2,520 pharmaceutical patents matching "treatment" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,520 results for “treatment” · 30,257 patents in full index Clear search

  1. US 9474787

    Mesenchymal stem cells for the treatment of CNS diseases

    BRAINSTORM CELL THERAPEUTICS LTD. · Granted Oct 25, 2016 · Expires Oct 20, 2036

    granted

  2. US 9468611

    d-Methadone for the treatment of psychiatric symptoms

    Relmada Therapeutics, Inc. · Granted Oct 18, 2016 · Expires Oct 13, 2036

    granted

  3. US 9463186

    Treatment for dopaminergic disorders

    Northwestern University · Granted Oct 11, 2016 · Expires Oct 6, 2036

    granted

  4. US 9463193

    Individual 5-fluorouracile dose optimization in folfiri treatment

    INSTITUT DE CANCEROLOGIE DE L'OUEST · Granted Oct 11, 2016 · Expires Oct 6, 2036

    granted

  5. US 9457030

    Compositions and methods for the treatment of juvenile neuronal ceroid lipofuscinosis and related disorders

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Oct 4, 2016 · Expires Sep 29, 2036

    granted

  6. US 9458507

    Antipsychotic treatment based on SNP genotype

    VANDA PHARMACEUTICALS INC. · Granted Oct 4, 2016 · Expires Sep 29, 2036

    granted

  7. US 9456997

    Selective inhibition of β1-adrenergic receptors for the treatment of pediatric heart failure

    The Regents of the University of Colorado, a Body Corporate · Granted Oct 4, 2016 · Expires Sep 29, 2036

    granted

  8. US 9457070

    Compositions, methods and uses of alpha 1-antitrypsin for early intervention in bone marrow transplantation and treatment of graft versus host disease

    The Regents of the University of Colorado, a Body Corporate · Granted Oct 4, 2016 · Expires Sep 29, 2036

    granted

  9. US 9457006

    Diagnosis and treatment methods for entry of gastrointestinal contents into respiratory tract

    The Regents of the University of California · Granted Oct 4, 2016 · Expires Sep 29, 2036

    granted

  10. US 9452175

    Pregnancy hormone combination for treatment of autoimmune diseases

    The Regents of the University of California · Granted Sep 27, 2016 · Expires Sep 22, 2036

    granted

  11. US 9453220

    RNAi-mediated inhibition of phosphodiesterase type 4 for treatment of cAMP-related ocular disorders

    Arrowhead Pharmaceuticals, Inc. · Granted Sep 27, 2016 · Expires Sep 22, 2036

    granted

  12. US 9445870

    Methods and devices for crosslinking of corneal collagen and for treatment of disorders of the eye

    Montefiore Medical Center · Granted Sep 20, 2016 · Expires Sep 15, 2036

    granted

  13. US 9446037

    Methods for the treatment of parkinson's disease psychosis using pimavanserin

    ACADIA Pharmaceuticals Inc. · Granted Sep 20, 2016 · Expires Sep 15, 2036

    granted

  14. US 9447406

    Chemically modified cystathionine beta-synthase enzyme for treatment of homocystinuria

    The Regents of the University of Colorado, a Body Corporate · Granted Sep 20, 2016 · Expires Sep 15, 2036

    granted

  15. US 9440990

    1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases

    Takeda Pharmaceutical Company Limited · Granted Sep 13, 2016 · Expires Sep 8, 2036

    granted

  16. US 9435804

    Detection, prevention, and treatment of anthrax and other infectious diseases

    BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE OF THE UNIVERSITY OF NEVADA, RENO · Granted Sep 6, 2016 · Expires Sep 1, 2036

    granted

  17. US 9433624

    Methods and compositions for the treatment of metabolic disorders

    BIOMARIN PHARMACEUTICAL INC. · Granted Sep 6, 2016 · Expires Sep 1, 2036

    granted

  18. US 9434758

    Non-hormonal steroid modulators of NF-κB for treatment of disease

    ReveraGen BioPharma, Inc. · Granted Sep 6, 2016 · Expires Sep 1, 2036

    granted

  19. US 9422556

    RNAi-related inhibition of TNF-alpha signaling pathway for treatment of ocular angiogenesis

    Arrowhead Pharmaceuticals, Inc. · Granted Aug 23, 2016 · Expires Aug 18, 2036

    granted

  20. US 9421240

    Compstatin analogs for treatment of neuropathic pain

    Apellis Pharmaceuticals, Inc. · Granted Aug 23, 2016 · Expires Aug 18, 2036

    granted

  21. US 9421185

    Diagnosis and treatment methods for entry of gastrointestinal contents into respiratory tract

    The Regents of the University of California · Granted Aug 23, 2016 · Expires Aug 18, 2036

    granted

  22. US 9408839

    Antipsychotic treatment based on DRD2 or ANKK1 SNP genotype

    VANDA PHARMACEUTICALS INC. · Granted Aug 9, 2016 · Expires Aug 4, 2036

    granted

  23. US 9410154

    HBV treatment

    Benitec Biopharma Limited · Granted Aug 9, 2016 · Expires Aug 4, 2036

    granted

  24. US 9402881

    Tissue regeneration and wound treatment methods with platelet derived compositions

    The Regents of the University of Colorado, a Body Corporate · Granted Aug 2, 2016 · Expires Jul 28, 2036

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.